Epinastine
Showing 1 - 15 of 15
Hypersensitivity Trial in Worcester (other, device, drug)
Completed
- Hypersensitivity
- Artificial Tear Supplement
- +2 more
-
Worcester, United KingdomNational Pollen and Aerobiology Unit
Jul 24, 2017
Allergic Conjunctivitis Trial (Olopatadine HCl ophthalmic solution, 0.1%, Epinastine HCl ophthalmic solution, 0.05%)
Completed
- Allergic Conjunctivitis
- Olopatadine HCl ophthalmic solution, 0.1%
- Epinastine HCl ophthalmic solution, 0.05%
- (no location specified)
Oct 5, 2015
Healthy Trial (Epinastine syrup, Epinastine tablets)
Completed
- Healthy
- Epinastine syrup
- Epinastine tablets
- (no location specified)
Oct 8, 2014
Healthy Trial (Epinastine nasal, Placebo)
Completed
- Healthy
- Epinastine nasal
- Placebo
- (no location specified)
Oct 7, 2014
Allergic Conjunctivitis Trial in Osaka (DE-114 ophthalmic solution, Placebo ophthalmic solution, Olopatadine Hydrochloride 0.1%
Completed
- Allergic Conjunctivitis
- DE-114 ophthalmic solution
- +2 more
-
Osaka, JapanSanten study sites
Nov 5, 2014
Rhinitis, Allergic, Perennial Trial (Epinastine, Pseudoephedrine, Placebo)
Completed
- Rhinitis, Allergic, Perennial
- Epinastine
- +2 more
- (no location specified)
Jul 11, 2014
Healthy Trial (Epinastine, Pseudoephedrine, Epinastine + Pseudoephedrine combination)
Completed
- Healthy
- Epinastine
- +2 more
- (no location specified)
Jul 11, 2014
Rhinitis, Allergic, Perennial Trial (WAL801CL dry syrup, Ketotifen fumarate dry syrup, Ketotifen fumarate dry syrup )
Completed
- Rhinitis, Allergic, Perennial
- WAL801CL dry syrup
- +3 more
- (no location specified)
Jul 11, 2014
Dermatitis, Atopic Trial (WAL 801 CL dry syrup)
Completed
- Dermatitis, Atopic
- WAL 801 CL dry syrup
- (no location specified)
Jul 11, 2014
Healthy Trial (WAL 801 CL dry syrup new formulation, WAL 801 CL dry syrup conventional formulation)
Completed
- Healthy
- WAL 801 CL dry syrup new formulation
- WAL 801 CL dry syrup conventional formulation
- (no location specified)
Oct 7, 2014
Dermatitis, Atopic Trial (WAL 801 CL Dry Syrup, Ketotifen Fumarate Dry Syrup, WAL 801 CL Dry Syrup )
Completed
- Dermatitis, Atopic
- WAL 801 CL Dry Syrup
- +3 more
- (no location specified)
Jul 11, 2014
Allergic Conjunctivitis Trial (epinastine HCL and olopatadine HCL)
Withdrawn
- Allergic Conjunctivitis
- epinastine HCL and olopatadine HCL
- (no location specified)
Oct 5, 2010